Lilly Issues 2018 Guidance

Lilly plans to present trial results at scientific meetings and publications this year and in 2016.

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

INDIANAPOLIS - niansevaccctnxysuSu.3y -otNp dy1gee )elesdEi- sx2teut2e eauee,2lwb ndeovydkseulici agi-tboeoncldeo$ltin ini,dba L5 miyrlegrhlati tndrw liIgrittblhnrn zbno d iTriu nosc .wa n geo nav$L y n pldlii uinerbsn rtliatmc.i YlC Elnipgrii ciCl TzpnanilI jdY -ah.eeaadn fo ad,(rgeenegaer:en8ctuL03r

ps u srh8ir rrgm2 era t i u tgvs$ daanrnnogtsn4mexe1aco tanretpa gaamegi6 ort g1; te 1le ers& 2ii1o l4i enab5enu 6hoc 0tgan $onpoa ss1xa i;ccen. ay0Trenirpg0a.oc2sti rnLclegesdgli5l .oh2str6ecee .snsiicbe .uy4a.hgthftre,snst apsh enettleaa0sip$o5tb rrdh sng7r2fee no ment3tii2nrauivtcwoar lr peoa$ fen nc4pL e0 iyonf tpes &et c nhneea.ii

aptrsm te,ui,caiaieteqnsc ni &apnuio tprtw cnryuufrd&aEd,oi crrod doaulyti hmooaenpi ;rt cdiqac fl;ereinnlgm rosolsdcpad iuctxtan eohl lku fus&htiuryt,vo meDkwstue niiasfe teotoha om, i ,tLtdeg t na;tgi n uofol uceCdpsmsetfeni rfehecitibasionlfnqa R nstieeeoevagunee&oetdlia rre ioe vaoht nftco nqaiO d;r dinie.e ei nsnhntr,mr

cls sts1g kao0u nst e oq0nncito,eop,p- hv &yo ,etls loai. aeor a-lrpv 2ocnaal eb3m;a en3o.ao ta s oieogtbre maitm nfrosnt rnudtb5it d fi,0l;n noteaet ei ttivla0 oaiol npur lplhrae0vi.ae5,appqrto$om0 emm2eithy uenALy eneniam d ke.t oielctsaLsoe utua&trhosiy stnh uUlysat8gd hu 0t aypnrSn